Not available
Quote | Ovid Therapeutics Inc. (NASDAQ:OVID)
Last: | $0.74 |
---|---|
Change Percent: | -1.56% |
Open: | $0.7506 |
Close: | $0.7517 |
High: | $0.7671 |
Low: | $0.74 |
Volume: | 68,262 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Ovid Therapeutics Inc. (NASDAQ:OVID)
The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic profile was achieved at the targeted clinical dose, supporting once daily d...
2024-06-30 09:10:33 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Breakfast: The Week Ahead
Message Board Posts | Ovid Therapeutics Inc. (NASDAQ:OVID)
Subject | By | Source | When |
---|---|---|---|
The trading last up | Mamameloconto | investorshub | 05/02/2023 1:18:07 PM |
The trading | MfridgeV2 | investorshub | 05/02/2023 3:37:39 AM |
Price trading last up | saj | investorshub | 05/01/2023 4:39:11 PM |
Price now last trade up | Mamameloconto | investorshub | 04/30/2023 3:54:51 PM |
$OVID When is this gonna take off? | Nfixus | investorshub | 04/30/2023 10:53:58 AM |
News, Short Squeeze, Breakout and More Instantly...
Ovid Therapeutics Inc. Company Name:
OVID Stock Symbol:
NASDAQ Market:
Ovid Therapeutics Inc. Website:
The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic profile was achieved at the targeted clinical dose, supporting once daily d...
2024-06-18 10:30:03 ET B. Riley analyst issues BUY recommendation for OVID on June 18, 2024 09:12AM ET. The previous analyst recommendation was Buy. OVID was trading at $0.7744 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...
2024-06-18 07:15:06 ET BTIG analyst issues BUY recommendation for OVID on June 18, 2024 04:51AM ET. The previous analyst recommendation was Buy. OVID was trading at $0.7896 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst r...